Cargando…

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines

The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Hajissa, Khalid, Mussa, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040488/
https://www.ncbi.nlm.nih.gov/pubmed/33830862
http://dx.doi.org/10.1080/21645515.2021.1900713
_version_ 1783677797198200832
author Hajissa, Khalid
Mussa, Ali
author_facet Hajissa, Khalid
Mussa, Ali
author_sort Hajissa, Khalid
collection PubMed
description The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mRNA) vaccine platform offers new opportunities for the development of effective vaccines. The first use of COVID-19 mRNA vaccines for individuals outside the clinical trials raised concerns over their safety and future efficacy. In social media, particularly in developing countries, widely shared false claims allege that the current mRNA-based COVID-19 vaccines potentially integrate into the host genome and thus may genetically modify humans. These vaccines are also assumed to lack efficacy due to the emergence of new strains. Such misinformation cause people to hesitate about receiving vaccination against COVID-19. This commentary aimed to outline the structure, mechanism of action and the major motive for the use of COVID-19 mRNA vaccine, with a focus on scientifically addressing challenges associated with conspiracy theories and dispelling misinformation around vaccination.
format Online
Article
Text
id pubmed-8040488
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-80404882021-04-13 Positive aspects of the mRNA platform for SARS-CoV-2 vaccines Hajissa, Khalid Mussa, Ali Hum Vaccin Immunother Commentary The unprecedented need to acquire a safe and effective vaccine for the long-term control of coronavirus disease 2019 (COVID-19) is a global imperative. Researchers have been working urgently and collaboratively to develop vaccines against the causative agent of COVID-19. The use of messenger RNA (mRNA) vaccine platform offers new opportunities for the development of effective vaccines. The first use of COVID-19 mRNA vaccines for individuals outside the clinical trials raised concerns over their safety and future efficacy. In social media, particularly in developing countries, widely shared false claims allege that the current mRNA-based COVID-19 vaccines potentially integrate into the host genome and thus may genetically modify humans. These vaccines are also assumed to lack efficacy due to the emergence of new strains. Such misinformation cause people to hesitate about receiving vaccination against COVID-19. This commentary aimed to outline the structure, mechanism of action and the major motive for the use of COVID-19 mRNA vaccine, with a focus on scientifically addressing challenges associated with conspiracy theories and dispelling misinformation around vaccination. Taylor & Francis 2021-04-08 /pmc/articles/PMC8040488/ /pubmed/33830862 http://dx.doi.org/10.1080/21645515.2021.1900713 Text en © 2021 Taylor & Francis Group, LLC
spellingShingle Commentary
Hajissa, Khalid
Mussa, Ali
Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
title Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
title_full Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
title_fullStr Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
title_full_unstemmed Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
title_short Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
title_sort positive aspects of the mrna platform for sars-cov-2 vaccines
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040488/
https://www.ncbi.nlm.nih.gov/pubmed/33830862
http://dx.doi.org/10.1080/21645515.2021.1900713
work_keys_str_mv AT hajissakhalid positiveaspectsofthemrnaplatformforsarscov2vaccines
AT mussaali positiveaspectsofthemrnaplatformforsarscov2vaccines